Beijing Balance Medical Technology Co., Ltd.

  • Market Cap: Large Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE100005X15
CNY
115.92
-2.29 (-1.94%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Jun'25
Mar'25
Dec'24
Sep'24
Jun'24
Mar'24
Dec'23
Net Sales
144.93
98.80
207.74
101.02
113.19
75.73
112.74
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
144.93
98.80
207.74
101.02
113.19
75.73
112.74
Raw Material Cost
23.06
23.24
31.77
12.97
17.05
12.94
15.23
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.32
0.11
0.10
0.12
0.12
0.12
0.17
Selling and Distribution Expenses
48.22
29.18
50.90
35.96
35.98
30.70
25.40
Other Expenses
3.43
2.66
3.74
3.18
3.31
3.63
3.25
Total Expenditure (Excl Depreciation)
105.91
79.16
120.20
80.86
86.28
80.04
73.34
Operating Profit (PBDIT) excl Other Income
39
19.6
87.5
20.2
26.9
-4.3
39.4
Other Income
3.52
14.65
6.21
2.06
3.12
8.82
9.04
Operating Profit (PBDIT)
52.95
44.69
101.50
22.22
34.97
9.45
52.84
Interest
0.32
0.11
0.10
0.12
0.12
0.12
0.17
Exceptional Items
-0.49
0.50
0.10
0.33
-0.10
0.42
-2.25
Gross Profit (PBDT)
121.88
75.56
175.97
88.05
96.14
62.80
97.50
Depreciation
10.41
10.41
7.76
0.00
4.94
4.94
4.40
Profit Before Tax
41.73
34.68
93.74
22.43
29.80
4.81
46.01
Tax
6.45
4.49
11.60
0.48
5.65
0.92
5.07
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
38.90
32.50
87.64
23.50
26.87
8.32
44.86
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
38.90
32.50
87.64
23.50
26.87
8.32
44.86
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
-3.62
-2.32
-5.50
-1.55
-2.72
-4.42
-3.92
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
35.28
30.18
82.14
21.96
24.15
3.90
40.94
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
1,218.02
1,287.12
1,252.60
1,171.94
1,131.90
1,207.12
1,194.61
Earnings per share (EPS)
0.28
0.24
0.64
0.17
0.2
0.06
0.33
Diluted Earnings per share
0.28
0.24
0.64
0.17
0.2
0.06
0.33
Operating Profit Margin (Excl OI)
26.92%
19.87%
42.14%
19.96%
23.77%
-5.68%
34.95%
Gross Profit Margin
35.97%
45.63%
48.86%
22.21%
30.69%
12.87%
44.72%
PAT Margin
26.84%
32.9%
42.19%
23.27%
23.74%
10.99%
39.79%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - QoQ
stock-summary

Net Sales

QoQ Growth in quarter ended Jun 2025 is 46.66% vs -52.43% in Mar 2025

stock-summary

Consolidate Net Profit

QoQ Growth in quarter ended Jun 2025 is 16.89% vs -63.22% in Mar 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended Jun 2025 is 64.67% vs -68.52% in Mar 2025

stock-summary

Interest

QoQ Growth in quarter ended Jun 2025 is 200.00% vs 0.00% in Mar 2025

stock-summary

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended Jun 2025 has improved from Mar 2025

Compare Quarterly Results Of Beijing Balance Medical Technology Co., Ltd. With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(CNY)
Change(%)
Net Sales
144.93
0
144.93
Other Operating Income
0.00
0.00
0.00
Total Operating income
144.93
0
144.93
Raw Material Cost
23.06
0
23.06
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
0.32
0
0.32
Selling and Distribution Expenses
48.22
0
48.22
Other Expenses
3.43
0.00
3.43
Total Expenditure (Excl Depreciation)
105.91
0
105.91
Operating Profit (PBDIT) excl Other Income
39.02
0.00
39.02
Other Income
3.52
0
3.52
Operating Profit (PBDIT)
52.95
0
52.95
Interest
0.32
0
0.32
Exceptional Items
-0.49
0
-0.49
Gross Profit (PBDT)
121.88
0
121.88
Depreciation
10.41
0
10.41
Profit Before Tax
41.73
0
41.73
Tax
6.45
0
6.45
Provisions and contingencies
0
0
0.00
Profit After Tax
38.90
0
38.90
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
38.90
0
38.90
Share in Profit of Associates
0
0
0.00
Minority Interest
-3.62
0
-3.62
Other related items
0.00
0.00
0.00
Consolidated Net Profit
35.28
0
35.28
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
1,218.02
0
1,218.02
Earnings per share (EPS)
0.28
0
0.28
Diluted Earnings per share
0.28
0
0.28
Operating Profit Margin (Excl OI)
26.92%
0%
0.00
26.92%
Gross Profit Margin
35.97%
0%
0.00
35.97%
PAT Margin
26.84%
0%
0.00
26.84%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 14.49 Million
in Jun 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2025 is 46.66% vs -52.43% in Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 is 28.00% vs 10.87% in Jun 2024

Quarterly - Consolidate Net Profit
Consolidate Net Profit 3.53 Million
in Jun 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2025 is 16.89% vs -63.22% in Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 is 45.87% vs -24.84% in Jun 2024

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 4.94 Million
in Jun 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2025 is 64.67% vs -68.52% in Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 is 55.35% vs 6.00% in Jun 2024

Quarterly - Interest
Interest 0.03 Million
in Jun 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2025 is 200.00% vs 0.00% in Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 is 200.00% vs 0.00% in Jun 2024

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 26.92%
in Jun 2025

Figures in %
stock-summary

QoQ Growth in quarter ended Jun 2025 has improved from Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 has improved from Jun 2024